Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
VAXX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2024-Revenue
2024-EPS
2024-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Earnings Growth
YoY
Current
Estimates
Q1.22
N/A
-0.31
vs -0.26
Q2.22
N/A
-0.14
vs -0.22
Q3.22
N/A
-0.15
vs -0.24
Q4.22
N/A
-0.16
vs -0.48
Q1.23
N/A
-0.15
vs -0.31
Q2.23
N/A
-0.11
vs -0.14
Q3.23
N/A
-0.10
vs -0.15
Q4.23
N/A
-0.09
vs -0.16
Q1.24
N/A
-0.10
vs -0.15
Q2.24
N/A
-0.10
vs -0.11
Sales Growth
YoY
Current
Estimates
Q3.21
-57%
50K vs 117K
Q4.21
NA
-1000.00 vs NA
Q1.22
-100%
NA vs 17K
Q2.22
NA
NA vs NA
Q3.22
-100%
NA vs 50K
Q4.22
+100%
NA vs -1000
Q1.23
NA
NA vs NA
Q2.23
NA
NA vs NA
Q3.23
NA
NA vs NA
Q4.23
NA
NA vs NA
Return on Equity
QoQ
Q1.22
-16%
-0.16
vs -0.37
Q2.22
-18%
-0.18
vs -0.16
Q3.22
-24%
-0.24
vs -0.18
Q4.22
-33%
-0.33
vs -0.24
Q1.23
-40%
-0.40
vs -0.33
Q2.23
-40%
-0.40
vs -0.40
Q3.23
-55%
-0.55
vs -0.40
Q4.23
-85%
-0.85
vs -0.55
Institutionnal Ownership
QoQ
Q3.22
29
29
vs 29
NA
Q4.22
30
30
vs 29
3%
Q1.23
46
46
vs 30
53%
Q2.23
48
48
vs 46
4%
Q3.23
51
51
vs 48
6%
Q4.23
58
58
vs 51
14%
Q1.24
56
56
vs 58
-3%
Q2.24
6
6
vs 56
-89%
Quote Panel
Key Metrics
finbold.com
6 hours ago
globenewswire.com
6 hours ago
investorplace.com
8 hours ago
investorplace.com
8 hours ago
globenewswire.com
16 hours ago
globenewswire.com
18 hours ago
Relative Strength
VAXX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|